A fully-integrated CE-marked and FDA Class I medical device demonstrating both open design and capability for locked methods, will be showcased at MSACL EU 2017 September 08, 2017 WARRINGTON UK — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in life science industry, will be showcasing the SCIEX Topaz™ System for Clinical Diagnostics at the... Read more
High Throughput Mass Spectrometry-Based Clinical Solution Can Run Hundreds of Samples Per Day APHL Newborn Screening and Genetic Testing Symposium, New Orleans, Booth #409– September 8, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its QSight® 210 MD system, designed to provide routine high... Read more
Basel, 08 September 2017 Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress First data on new blood-based assay for measuring tumour mutational burden Two prospective studies underway to assess the potential of tumour mutational burden to predict response to certain cancer immunotherapies Roche (SIX: RO, ROG;... Read more
Provides Families a Novel, Personalized Approach to Managing their Health WALTHAM, Massachusetts – September 7, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction... Read more
Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe HEIDELBERG, Germany and CARLSBAD, Calif., Sept. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Pathology Heidelberg (IPH) to establish its Center of Molecular Pathology at Heidelberg University Hospital as... Read more
MINNEAPOLIS, Sept. 6, 2017 /PRNewswire/ — R&D Systems®, a Bio-Techne brand, announced today the release of a new rapid, solid phase, enzyme-linked immunosorbent assay (ELISA) designed to measure anti-Zika virus immunoglobulin G (IgG) antibodies in human serum. A unique feature of this assay is that, prior to performing the test, samples are pre-treated with a proprietary... Read more
Cambridge, UK, September 06, 2017 Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensed Congenica’s Sapientia™ software platform to perform analysis of whole-exome sequencing data and... Read more
Basel, 06 September 2017 Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer ALUR study shows 85% reduction in risk of disease worsening or death versus chemotherapy in patients with advanced ALK-positive NSCLC who had progressed on chemotherapy and crizotinib Roche (SIX: RO,... Read more
Awarded to the Agilent IQFISH Panel for Lung Cancer SANTA CLARA, Calif., September 5, 2017 Agilent Technologies Inc. (NYSE: A) has received a 2017 Scientists’ Choice Award for Best New Clinical Laboratory Product: the IQFISH Panel for Lung Cancer. The IQFISH panel for lung cancer makes it easier for pathology labs to integrate fast, high-quality... Read more
New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings Analysis shows that high quality BRAHMS PCT (procalcitonin) assays are reliable tools to assist in the safe management of patients with suspected bacterial infection and sepsis HENNIGSDORF, Germany, Sept. 5, 2017 /PRNewswire/ — A new study, recently... Read more